Episode Summary
For lung cancer patients, the benefits of treatment and potential for cure must always be balanced with risk. Cardiotoxicity is considered a short and long term risk from treatment for lung cancer, but this varies between patients. New radiotherapy techniques, lower doses of radiotherapy and supporting cardiovascular treatments can minimise the risk of cardiotoxicity. Monitoring for cardiac complications is becoming an important aspect of survivorship care, and may require collaboration between medical oncologists, radiation oncologists, GPs and cardiologists. Prof Shalini Vinod discusses the challenges with Dr Vicky Chin and Dr James Otton.
Show Hosts
This episode’s host are:
- Prof Shalini Vinod, Communications and Grants Chair, TOGA; Radiation Oncologist, Liverpool Hospital; Conjoint Professor University of New South Wales; Honorary Professor, University of Wollongong
- Dr Vicky Chin, Radiation Oncologist, University of New South Wales
- A/Prof James Otton, Cardiologist, Liverpool Hospital
